Sartorius Stedim Biotech
Sartorius Stedim Biotech SA is a French bioprocess technology provider supplying equipment and solutions for the pharmaceutical industry. The company operates dedicatedly within the bioprocess solutions sector, serving drug discovery and biopharmaceutical manufacturing. Its main product suite comprises single-use bioreactors, membrane filtration systems, fluid management bags, and purification technologies. Revenues are primarily driven by high-margin recurring sales of single-use consumable products alongside capital equipment installations for biopharma manufacturing facilities. The company holds a market-leading global position in single-use bioprocessing solutions used to manufacture biopharmaceuticals and vaccines. Sartorius Stedim Biotech is headquartered in Aubagne, France, and listed on Euronext Paris.
35 of the funds FundTelligence covers report a position in Sartorius Stedim Biotech.
- Sector
- Health Care
- Country
- France
- Funds holding it
- 35
Funds holding Sartorius Stedim Biotech
- Nordea Sustainable Water — Nordea Funds · 2.29 % (full portfolio disclosed, September 2026)
- BNP Euro Equity — BNP Paribas · 1.25 % (full portfolio disclosed, June 2026)
- T. Rowe Price European Equity Fund — T. Rowe Price · 1.01 % (full portfolio disclosed, September 2026)
- BlackRock iShares MSCI Europe Health Care Sector UCITS ETF — BlackRock · 0.37 % (full portfolio disclosed, October 2026)
- Franklin Biotechnology Discovery Fund — Franklin Templeton · 0.23 % (full portfolio disclosed, September 2026)
- Storebrand Europe Index — Storebrand · 0.1 % (full portfolio disclosed, October 2026)
- Danske Invest Europe Index Restricted — Danske Invest · 0.06 % (full portfolio disclosed, July 2026)
- BlackRock iShares MSCI Europe Screened UCITS ETF — BlackRock · 0.06 % (full portfolio disclosed, October 2026)
Showing the 8 largest of 35 funds holding it.